Virpax Pharmaceuticals, Inc. short interest in 2021
In 2021, Virpax Pharmaceuticals, Inc.'s disclosed short interest ran from 0.14% of shares outstanding on 14 May 2021 to 1.73% on 31 Dec 2021, a change of +1.59 percentage points. The year's high was 6.69% on 15 Sep 2021 and its low 0.14% on 14 May 2021, averaging 3.56% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.00 days on 14 May 2021. Full history: Virpax Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024
2021 in figures
- Start of year
- 0.14% (14 May 2021)
- End of year
- 1.73% (31 Dec 2021)
- Change
- +1.59 pp
- High
- 6.69% (15 Sep 2021)
- Low
- 0.14% (14 May 2021)
- Average
- 3.56%
- Highest days to cover
- 1.00 (14 May 2021)
- SEC filings marked
- 7
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 May 2021 | 0.14% | 1.00 | 10-K filed |
| 13 Aug 2021 | 2.43% | 1.00 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Aug 2021 | 4.94% | 1.00 | |
| 15 Sep 2021 | 6.69% | 1.00 | |
| 30 Sep 2021 | 5.95% | 1.00 | |
| 15 Oct 2021 | 4.45% | 1.00 | |
| 29 Oct 2021 | 4.81% | 1.00 | |
| 15 Nov 2021 | 1.96% | 1.00 | 10-Q filed, results (8-K) |
| 15 Dec 2021 | 2.50% | 1.00 | |
| 31 Dec 2021 | 1.73% | 1.00 |
See also: Virpax Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.